Analyst Research: Allergan plc (AGN)

AGN on New York Consolidated

331.00USD
4 Aug 2015
Change (% chg)

$-3.92 (-1.17%)
Prev Close
$334.92
Open
$334.62
Day's High
$337.95
Day's Low
$330.88
Volume
2,213,522
Avg. Vol
2,180,283
52-wk High
$340.34
52-wk Low
$201.91

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Allergan plc (AGN-N) 5:38am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (WPI). A detailed report, including free correlated market analysis, and updates. 1:22am EDT Stock Traders Daily 5 20.00
Trading Report for (AGN). A detailed report, including free correlated market analysis, and updates. 3 Aug 2015 Stock Traders Daily 12 20.00
Trading Report for (ACT). A detailed report, including free correlated market analysis, and updates. 3 Aug 2015 Stock Traders Daily 6 20.00
AGN: Due Diligence Review: Forensic Earnings and Valuation 3 Aug 2015 New Constructs, LLC 10 25.00
ValuEngine Industry Report for Medical-Generic Drugs(AGN) 2 Aug 2015 ValuEngine, Inc. 10 49.00
ValuEngine Rating and Forecast Report for AGN 2 Aug 2015 ValuEngine, Inc. 10 25.00
Allergan plc 1 Aug 2015 S&P Capital IQ – STARS Reports 11 127.00
ALLERGAN INC (AGN) - REPORT FOR ACTIVE TRADERS 31 Jul 2015 Pechala's Reports 1 25.00
ALLERGAN INC (AGN) 12-months forecast 31 Jul 2015 Pechala's Reports 1 15.00
 
Name Age Since Current Position

Paul Bisaro

54 2014 Executive Chairman of the Board

Brenton Saunders

45 2014 President, Chief Executive Officer, Director

Maria Hilado

50 2014 Chief Financial Officer, Executive Vice President

Robert Stewart

47 2014 Chief Operating Officer, Executive Vice President

Karen Ling

51 2014 Chief Human Resource Officer
Search Stocks